Stock GLTO GALECTO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Galecto, Inc.

Equities

GLTO

US36322Q1076

Delayed Nasdaq
Other stock markets
 14:17:23 2024-07-17 EDT 		5-day change 1st Jan Change
0.5724 USD +0.42% Intraday chart for Galecto, Inc. +11.78% -22.22%
06-10 Oppenheimer Adjusts Price Target on Galecto to $9 From $10, Maintains Outperform Rating MT
05-01 Galecto, Inc. Announces First Patient Dosed in an Investigator-Initiated Phase 2 Trial of GB1211 in Combination with Pembrolizumab CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
GALECTO, INC.
Bio Therapeutic Drugs
+0.42%+11.78%-22.22%-75.76% - 15.45M
Neutral
Bearish
Bearish
  1. Stock Market
  2. Equities
  3. GLTO Stock
  4. Charts Galecto, Inc.
  5. Relative Strength Chart